Stay updated on CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial
Sign up to get notified when there's something new on the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page.

Latest updates to the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page
- Check4 days agoChange DetectedNew history entries for 2026-05-27 to 2026-05-29 introduce versions 330 and 331 with updates to Study Status and Contacts/Locations. An entry dated 2026-05-20 was removed.SummaryDifference0.1%

- Check11 days agoChange DetectedThe latest revision adds a Contacts/Locations section and a Study Status update to the record, signaling updated administrative details and the study's current status, while removing a prior entry dated 2026-05-18.SummaryDifference0.1%

- Check19 days agoChange DetectedVersion 3.5.4 introduces core updates to the record by adding the Arms and Interventions section, and by updating the Study Status and Contacts/Locations. The change is reflected with the new Revision: v3.5.4 label.SummaryDifference0.3%

- Check26 days agoChange DetectedAdds two new entries to the record history: Contacts/Locations and Study Status, dated 2026-05-05 and 2026-05-06, respectively. It also removes the historical entry dated 2026-05-01.SummaryDifference0.1%

- Check33 days agoChange DetectedOn 2026-05-01, Contacts/Locations and Study Status were added to the study record history. This update provides visibility into where the study is conducted and its current status, aiding users in understanding who to contact and the study’s progress.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a minor site/version change without changing the study record content.SummaryDifference0.0%

Stay in the know with updates to CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page.